Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 2Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 1215Neoplasms 1024Carcinoma, Non-Small-Cell Lung 747Prostatic Neoplasms 687Colorectal Neoplasms 590Lung Neoplasms 572Pancreatic Neoplasms 394Leukemia, Myeloid, Acute 394Neoplasm Metastasis 387Ovarian Neoplasms 370Multiple Myeloma 369Stomach Neoplasms 316Carcinoma, Hepatocellular 301Melanoma 281Brain Neoplasms 277Recurrence 273Squamous Cell Carcinoma of Head and Neck 267Head and Neck Neoplasms 237Endometrial Neoplasms 234Glioblastoma 233Triple Negative Breast Neoplasms 228Uterine Cervical Neoplasms 221Precursor Cell Lymphoblastic Leukemia-Lymphoma 221Lymphoma 221Sarcoma 201Hematologic Neoplasms 199Urinary Bladder Neoplasms 196Esophageal Neoplasms 190Carcinoma, Renal Cell 187Lymphoma, Non-Hodgkin 175

Interventions

Surveys and Questionnaires 1Gabapentin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Bipolar Disorder × 1 year × Clear all
NCT07398365 2026-05-05

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

University of Edinburgh

Recruiting
100 enrolled

Psychological Well-Being, Bipolar Disorder, Depression, Neoplasms, Personality Disorders, Psychotic Disorders, Respiration Disorders, Schizophrenia

NCT05064319 2025-07-08

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Medical University of South Carolina

Phase 2 Recruiting
68 enrolled
Lymphoid

Bipolar Disorder, Lymphoma, Follicular, Psychotic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡